Aclarion Says Enrollment Insufficient For Q4 2026 Initial Readout Of CLARITY Trial; Will Update Timing By Year-End, Says Overall Trial Duration Unchanged

Benzinga Newsdesk www.benzinga.com Neutral 69.7%

Neg 0% Neu 69.7% Pos 0%

Comments

No comments yet. Be the first!